Author: Rhein, Bethany A.; Powers, Linda S.; Rogers, Kai; Anantpadma, Manu; Singh, Brajesh K.; Sakurai, Yasuteru; Bair, Thomas; Miller-Hunt, Catherine; Sinn, Patrick; Davey, Robert A.; Monick, Martha M.; Maury, Wendy
Title: Interferon-? Inhibits Ebola Virus Infection Document date: 2015_11_12
ID: 10bu7iwg_21
Snippet: Consistent with reduced morbidity and mortality in the EBOV GP/rVSV infected, IFNγtreated mice, mice treated with 3.3 μg of IFNγ at 24 hour before infection had dramatically lower EBOV GP/rVSV viremia at day 2 of infection ( Fig 5B) . Little to no detectable viral load was observed in liver, peritoneal lymph nodes or brain, of the pre-treated mice with somewhat higher levels of virus present in the spleen. Similar trends were observed in mice .....
Document: Consistent with reduced morbidity and mortality in the EBOV GP/rVSV infected, IFNγtreated mice, mice treated with 3.3 μg of IFNγ at 24 hour before infection had dramatically lower EBOV GP/rVSV viremia at day 2 of infection ( Fig 5B) . Little to no detectable viral load was observed in liver, peritoneal lymph nodes or brain, of the pre-treated mice with somewhat higher levels of virus present in the spleen. Similar trends were observed in mice treated with IFNγ 2 hours following EBOV GP/rVSV infection (Fig 5B) , but splenic virus loads were higher in these mice, suggesting that some virus had trafficked to the spleen by 2 hours following inoculation. Nonetheless, IFNγ treatment still controlled virus titers in other organs.
Search related documents:
Co phrase search for related documents- GP rvsv and IFNγ treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- GP rvsv infection and IFNγ μg: 1, 2, 3, 4, 5
- GP rvsv infection and IFNγ treatment: 1, 2, 3, 4, 5, 6, 7
- lymph node and mortality reduce morbidity: 1, 2
- lymph node and peritoneal lymph node: 1, 2, 3, 4, 5, 6, 7, 8
Co phrase search for related documents, hyperlinks ordered by date